Researchers analyzed data from 15 previous studies involving nearly 280,000 people with multiple myeloma. They wanted to understand whether having this blood cancer affects a person's risk of developing a completely different second cancer later on. They compared the cancer rates in these patients to what would be expected in the general population.
The main finding was that the overall risk of developing any second primary cancer was not significantly higher for multiple myeloma patients. However, when looking at specific cancer types, the picture was more complex. The risk of developing a second blood cancer was markedly increased—about three times higher than expected. The analysis also identified specific solid tumors where risk was either increased or decreased.
This was an observational meta-analysis, which means it combined existing data to look for patterns and associations. It cannot prove that multiple myeloma causes these second cancers. The study did not report absolute risk numbers, so we don't know how common these second cancers actually are. The authors suggest that cancer follow-up strategies should consider these site-specific risks rather than using a one-size-fits-all approach.
Readers should understand this research identifies a pattern that needs further study, not a definitive cause-and-effect relationship. People with multiple myeloma should continue with their recommended follow-up care and discuss any concerns about cancer risk with their healthcare team.